Traub law office logo image

FDA issues warning on four asthma drugs

The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions to lower an uncommon but potentially life-threatening risk that asthma could worsen suddenly. The warnings cover the drugs Advair, Symbicort, Foradil and Serevent. The FDA said they should be used only by asthmatics who can’t control their disease with other drugs — and then only for the shortest time possible.

About Andrew Traub

1415b4ab9c1ee8d44e10422754ca1751Andrew is the owner and founder of The Traub Law Office, P.C.

View all articles by Andrew Traub | Website

Back To Top